Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Multiple drugs

Stevens-Johnson syndrome, toxic epidermal necrolysis and its worsening: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat MATSUMOTO K, et al. Topical Betamethasone Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Involvement in the Acute Phase. American Journal of Ophthalmology 253: 142-151, Sep 2023. Available from: URL: https://www.elsevier.com/locate/ajo MATSUMOTO K, et al. Topical Betamethasone Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Involvement in the Acute Phase. American Journal of Ophthalmology 253: 142-151, Sep 2023. Available from: URL: https://​www.​elsevier.​com/​locate/​ajo
Metadaten
Titel
Multiple drugs
Stevens-Johnson syndrome, toxic epidermal necrolysis and its worsening: 7 case reports
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49241-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Nevirapine

Case report

Multiple drugs

Case report

Decitabine

Case report

Dexamethasone

Case report

Multiple drugs